Zenotech Lab. — 360° view

Zenotech Lab, a company in the Pharmaceuticals industry, reported revenue of ₹7.15 crore and a net loss of ₹2.57 crore for the September 2026 quarter.

Zenotech Lab. (BSE: ZENOTECH) closed at ₹38.80 on 20 Nov 2026, down 22.9% over the past year. Its market capitalisation is ₹237 crore.

Share price
₹38.80 (20 Nov 2026)
Market cap
₹237 Cr (20 Nov 2026)
Revenue
₹7 Cr (September 2026 quarter)
Net profit
₹-3 Cr (September 2026 quarter)
ROCE
4.59% (FY26)
ROE
-1.15% (FY26)
Book value
₹15.1 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹50.93 / ₹33.55 (20 Nov 2026)
1-year return
-22.9% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: ZENOTECH

Incorporated in 1989, Zenotech Laboratories Ltd is in the business of manufacturing biotechnology products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.